Evercore ISI analyst Stephen Kim maintained a Buy rating on DR Horton today and set a price target of $185.00. The company’s shares opened today at $153.76.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kim covers the Consumer Cyclical sector, focusing on stocks such as DR Horton, Installed Building Products, and KB Home. According to TipRanks, Kim has an average return of 14.7% and a 58.82% success rate on recommended stocks.
DR Horton has an analyst consensus of Hold, with a price target consensus of $154.40, which is a 0.42% upside from current levels. In a report released today, UBS also maintained a Buy rating on the stock with a $187.00 price target.
The company has a one-year high of $199.85 and a one-year low of $110.44. Currently, DR Horton has an average volume of 3.67M.
Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DHI in relation to earlier this year. Last month, Michael Buchanan, a Director at DHI sold 2,150.00 shares for a total of $274,533.50.
Read More on DHI:
- D.R. Horton price target raised to $187 from $176 at UBS
- D.R. Horton price target raised to $170 from $155 at Wedbush
- D.R. Horton price target raised to $117 from $105 at RBC Capital
- D.R. Horton price target raised to $175 from $160 at Wells Fargo
- Balanced Outlook on DR Horton Amid Impressive Earnings and Market Challenges